DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $81,000 | -35.7% | 275 | -28.4% | 0.02% | -27.3% |
| Q4 2021 | $126,000 | +7.7% | 384 | 0.0% | 0.02% | +4.8% |
| Q3 2021 | $117,000 | +13.6% | 384 | 0.0% | 0.02% | +16.7% |
| Q2 2021 | $103,000 | +19.8% | 384 | 0.0% | 0.02% | +5.9% |
| Q1 2021 | $86,000 | +1.2% | 384 | 0.0% | 0.02% | -5.6% |
| Q4 2020 | $85,000 | +2.4% | 384 | 0.0% | 0.02% | -10.0% |
| Q3 2020 | $83,000 | +29.7% | 384 | +6.1% | 0.02% | +17.6% |
| Q2 2020 | $64,000 | +68.4% | 362 | +31.6% | 0.02% | +41.7% |
| Q1 2020 | $38,000 | -13.6% | 275 | -4.5% | 0.01% | 0.0% |
| Q4 2019 | $44,000 | +4.8% | 288 | -1.4% | 0.01% | -7.7% |
| Q3 2019 | $42,000 | 0.0% | 292 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $42,000 | +20.0% | 292 | +9.4% | 0.01% | 0.0% |
| Q1 2019 | $35,000 | +25.0% | 267 | 0.0% | 0.01% | +8.3% |
| Q4 2018 | $28,000 | -3.4% | 267 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $29,000 | +11.5% | 267 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $26,000 | 0.0% | 267 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $26,000 | +4.0% | 267 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $25,000 | +8.7% | 267 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $23,000 | +15.0% | 267 | +10.8% | 0.01% | 0.0% |
| Q2 2017 | $20,000 | -4.8% | 241 | 0.0% | 0.01% | -9.1% |
| Q1 2017 | $21,000 | +10.5% | 241 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $19,000 | -5.0% | 241 | -3.6% | 0.01% | -15.4% |
| Q3 2016 | $20,000 | -16.7% | 250 | +4.2% | 0.01% | -23.5% |
| Q2 2016 | $24,000 | +4.3% | 240 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $23,000 | +4.5% | 240 | +2.6% | 0.02% | -5.6% |
| Q4 2015 | $22,000 | 0.0% | 234 | -11.4% | 0.02% | -10.0% |
| Q3 2015 | $22,000 | +4.8% | 264 | +5.6% | 0.02% | +11.1% |
| Q2 2015 | $21,000 | 0.0% | 250 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $21,000 | 0.0% | 250 | 0.0% | 0.02% | -5.3% |
| Q4 2014 | $21,000 | +10.5% | 250 | 0.0% | 0.02% | +11.8% |
| Q3 2014 | $19,000 | +5.6% | 250 | +7.3% | 0.02% | +6.2% |
| Q2 2014 | $18,000 | +5.9% | 233 | 0.0% | 0.02% | +6.7% |
| Q1 2014 | $17,000 | -5.6% | 233 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $18,000 | – | 233 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |